International Society for Pharmacoeconomics and Outcomes Research (ISPOR)

What International Society for Pharmacoeconomics and Outcomes Research (ISPOR) does

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a US-incorporated nonprofit professional society founded in 1995 and headquartered in Lawrenceville, NJ, dedicated to advancing health economics and outcomes research (HEOR) as a discipline. The organization serves a global multidisciplinary community of researchers and academicians, regulators and health technology assessors, public and private payers, the healthcare industry (pharmaceutical, biotechnology, medical device, and diagnostics companies), and patient representatives. ISPOR does not develop proprietary technology products; instead it functions as a standards-setting and convening body for the field, producing peer-reviewed journals (Value in Health, Value in Health Regional Issues, Value & Outcomes Spotlight), Good Practices Reports including the CHEERS reporting guidelines, the HEOR Competencies Framework, and a global network of Special Interest Groups, Task Forces, Regional Chapters, Student Chapters, and Councils.

ISPOR monetizes its mission through a diversified revenue base: individual and corporate membership dues (recurring subscriptions), conference and event registration across the ISPOR Annual Conference, ISPOR Europe, ISPOR Asia Pacific Summit, and the new ISPOR Healthcare Investment Summit, educational programs delivered through the ISPOR Education Center, HEOR Learning Lab, short courses, and webinars, and revenues from peer-reviewed publications. Distribution is global, with the society claiming presence across 100+ countries and serving as the leading HEOR society worldwide. The organization's GTM motion is community-led: engagement flows through membership, conference participation, publication submissions, and active participation in SIGs and task forces, with secondary reach via its website, email newsletters, webinars, and social media.

The organization operates with a lean staff of 11-50 employees, reflecting an asset-light professional society model that relies on volunteer leadership, editorial boards, and member participation to deliver its programming. Strategic direction is set by the Board of Directors, with a publicly articulated Strategic Plan 2030 covering initiatives such as the ISPOR Institute, Women in HEOR, Diversity at ISPOR, and expanded dialogue with decision makers. Recent strategic activity has emphasized topical and geographic expansion (Environmental Assessment, Health Equity, Asia Pacific, Healthcare Investment) and early positioning around AI as a methodological topic via the GenAI for HEOR SLRs Task Force.

Name

International Society for Pharmacoeconomics and Outcomes Research (ISPOR)

Legal name

International Society for Pharmacoeconomics and Outcomes Research, Inc

Website

https://ispor.org

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

11–50 employees

Short description

ISPOR is a US-based nonprofit professional society founded in 1995 that serves the global health economics and outcomes research (HEOR) community through peer-reviewed journals, major conferences, educational programs, and member-driven special interest groups. It is funded via membership dues, conference registration, publications, and corporate partnerships.

Ownership category

akta.pro rank

Product category

Professional Society and Healthcare Research Services

NAICS

Business Associations (813910), Convention and Trade Show Organizers (56192)

SIC

Services-Membership Organizations (8600)

akta.pro primary industry

Health Economics & Outcomes Research (HEOR) (HLAIAKAB)

Keywords

• Health economics research
• Outcomes research society
• Pharmacoeconomics publications
• Healthcare conferences
• Professional membership society

Headquarters

HQ city

Lawrenceville

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Membership Dues: ISPOR generates revenue through individual and organizational membership fees. The society offers various membership categories including student membership, individual membership, and corporate partnerships.
2. Conference and Event Registration: Revenue generated from registration fees for ISPOR conferences including ISPOR Annual Conference, ISPOR Europe, ISPOR Asia Pacific Summit, and Healthcare Investment Summit.
3. Educational Programs and Short Courses: Revenue from the ISPOR Education Center, HEOR Learning Lab, short courses, and webinars providing on-demand HEOR education.
4. Publications: Revenue from peer-reviewed journals including Value in Health, Value in Health Regional Issues, and Value & Outcomes Spotlight. Journals are Medline-indexed and serve the HEOR community.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

ISPOR is a global professional society that delivers health economics and outcomes research (HEOR) resources through paid individual and corporate memberships, peer-reviewed journals, annual and regional scientific conferences, online education programs, and methodology guidance documents. The society operates as the leading international forum for HEOR professionals, providing members and customers with access to scientific publications, continuing education, networking communities, and Good Practices Reports that establish methodological standards in the field.

Product overview

ISPOR is a professional society offering a comprehensive portfolio of HEOR resources, publications, education, conferences, and member communities. The core offerings include three peer-reviewed journals (Value in Health, Value in Health Regional Issues, Value & Outcomes Spotlight), an education platform with the ISPOR Education Center and HEOR Learning Lab, knowledge resources including the Presentations Database, Good Practices Reports, and HEOR Competencies Framework. The society organizes major conferences (ISPOR Asia Pacific Summit, ISPOR Europe, ISPOR Annual Conference), supports member communities through Special Interest Groups, Task Forces, Student Network, and Faculty Advisor Council, and provides awards and travel grants to foster research excellence in health economics and outcomes research.

Differentiator

Problem solved

Functional benefit

Products and services

• Value in Health International, high-impact, Medline-indexed peer-reviewed journal that publishes original research and health policy articles advancing the field of health economics and outcomes research, for HEOR researchers, clinicians, payers, and policy makers.
• Value in Health Regional Issues Peer-reviewed journal covering health economics and outcomes research specific to geographic regions, serving regional HEOR communities and decision-makers.
• Value & Outcomes Spotlight Society publication providing coverage of health economics and outcomes research topics, society news, and member-relevant content for the HEOR community.
• ISPOR Education Center On-demand HEOR education platform delivering personalized, flexible learning programs to health economics and outcomes research professionals and students.
• HEOR Learning Lab Interactive online learning resource providing structured health economics and outcomes research education to professionals and students.
• Short Courses In-person educational short courses covering health economics and outcomes research methodologies and applications, targeted at conference attendees and HEOR professionals.
• HEOR Webinars Live and on-demand webinars providing convenient access to core and trending topics in health economics and outcomes research for members and non-members.
• ISPOR Presentations Database Searchable online database of conference presentations and scientific research from ISPOR events, providing members access to the society's conference scientific content.
• Good Practices Reports Methodological guidance documents including CHEERS statements and other good practices reports providing standardized frameworks for health economics and outcomes research.
• HEOR Competencies Framework Framework defining 41 competencies across 13 topic domains for health economics and outcomes research professionals, used for career development and curriculum design.
• ISPOR Asia Pacific Summit 2026 Regional summit convening leading experts, policymakers, industry innovators, and patient organizations to explore how health economics and outcomes research advances affordable access to healthcare innovation across the Asia Pacific region.
• ISPOR Healthcare Investment Summit 2026 Summit focused on healthcare investment and finance within health economics and outcomes research, bringing together investors, payers, and HEOR leaders.
• ISPOR Europe 2026 Annual European conference for health economics and outcomes research, convening European and global HEOR researchers, industry professionals, and policymakers.
• ISPOR 2027 Annual North American conference for health economics and outcomes research, the society's flagship event convening global HEOR researchers, industry, payers, and patient representatives.

Quantifiable outcome

• Leading professional society for HEOR globally
• +1 more outcomes

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Corporate PartnersmajorOthersISPOR offers corporate partnership programs as part of its strategic initiatives, allowing companies in the healthcare industry to engage with the society and its global membership of HEOR professionals.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Health Technology Assessment International (HTAi): HTAi is the global professional society dedicated to health technology assessment, with overlapping membership in payers, regulators, and industry and a similar conference/journal model. It is the most directly comparable society to ISPOR, with a narrower scope on HTA rather than full HEOR.
• International Society for Quality of Life Research (ISOQOL): ISOQOL is a multidisciplinary, international society for researchers studying patient-reported outcomes and quality of life measurement. It directly overlaps ISPOR's Clinical Outcome Assessment and Patient-Centered Research SIGs and uses a similar journals-plus-annual-conference operating model.
• Society for Medical Decision Making (SMDM): SMDM is a professional society for researchers applying decision science, health economics, and clinical epidemiology to medical decisions. Its membership, annual meeting, and methods focus on shared ground with ISPOR's HEOR methodology SIGs.
• AcademyHealth: AcademyHealth is a U.S.-based professional society for health services and policy researchers with major conferences, journals, and an interest in HEOR and real-world evidence. It competes for similar academic and policy researcher members and overlapping conference sponsorship dollars.
• Academy of Managed Care Pharmacy (AMCP): AMCP is a U.S. professional society for pharmacists and payers focused on managed care, formulary management, and value-based care. It runs major annual meetings and serves as an alternative membership/education venue for payer-side HEOR professionals that ISPOR also targets.

Broad incumbents

• Drug Information Association (DIA): DIA is a large global life sciences professional society spanning regulatory, clinical, R&D, and pharmacovigilance content with multiple annual meetings and educational programs. It serves many of the same industry and regulatory professionals but covers a much broader scope than ISPOR's HEOR focus.
• National Comprehensive Cancer Network (NCCN): NCCN is a nonprofit alliance of leading cancer centers producing oncology guidelines that often incorporate HEOR evidence. While clinical-guideline focused, it overlaps with ISPOR's payer, industry, and HTA audiences in oncology value assessment and real-world evidence.

Emerging players

• ICHOM (International Consortium for Health Outcomes Measurement): ICHOM is a nonprofit that develops standardized outcome sets for value-based care and overlaps with ISPOR's outcomes research interest areas. It is smaller and more niche than ISPOR but represents an emerging standard-setting peer in patient-centered outcomes methodology.
• Society for Clinical Trials: The Society for Clinical Trials is a multidisciplinary professional society advancing clinical trial design and conduct, overlapping with HEOR methods through real-world evidence and pragmatic trials. It is a smaller comparator that shares ISPOR's researcher-oriented membership model.

Regional players

• European Society for Medical Oncology (ESMO): ESMO is the leading European oncology professional society with a major annual congress and growing interest in value-based cancer care and HEOR. It complements ISPOR Europe content with regionally focused clinical oncology programming that incorporates economic evidence.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/ispororg
• Facebookfacebook.com/100220853389399
• LinkedInlinkedin.com/company/ispororg

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about International Society for Pharmacoeconomics and Outcomes Research (ISPOR)